Skip to content

Insider · CIK 0001476171

Robert Mittendorff II

director

Files at CARL (CARLSMED, INC.). First filing Jul 24, 2025, latest Jul 24, 2025.

In brief

Robert Mittendorff II files SEC Form 4 as director at CARL (CARLSMED, INC.). Since Jul 24, 2025, Robert Mittendorff II has reported 1 open-market buy worth $20M and 0 open-market sells worth $0, the latest filed on Jul 24, 2025.

A track record needs three past buys with six months of prices behind them; Robert Mittendorff II has 0, so none is measured yet.

The newest scored trade: bought $20M of CARL on Jul 24, 2025, filed Jul 24, 2025, scored 71 (notable).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CARL: CARLSMED, INC.

CARLOct 12, 2026 · close 14.78

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
71Notable
CARLbuy 6
CARLSMED, INC.
$20M
1,333,333 shares
+36%0% from low-0% from high

Transactions

Every row this insider has filed, 9 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Common Stockindirect: See footnotes
+3,680,506--3,680,506Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
POpen-market purchase
Common Stockindirect: See footnotes
+1,333,333$15.00$20M5,013,839Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Common Stockindirect: See footnotes
+2,376,472--2,376,472Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Common Stockindirect: See footnotes
+931,452--931,452Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Series B Preferred Stockderivativeindirect: See footnotes
-1,445,020--0Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Series C Preferred Stockderivativeindirect: See footnotes
-2,235,486--0Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Series B Preferred Stockderivativeindirect: See footnotes
-1,445,020--0Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Series C Preferred Stockderivativeindirect: See footnotes
-931,452--0Jul 24, 2025
Jul 24, 2025CARL
CARLSMED, INC.
CConversion
Series C Preferred Stockderivativeindirect: See footnotes
-931,452--0Jul 24, 2025

Questions about Robert Mittendorff II

Answered from the filings on this page, as of the latest one.

Is Robert Mittendorff II buying or selling?

Not in the last 12 months. Robert Mittendorff II's latest open-market trade on SEC Form 4 was bought $20M of CARL on Jul 24, 2025.

How did Robert Mittendorff II's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Mittendorff II has 0.

Where does Robert Mittendorff II file Form 4?

Robert Mittendorff II has filed Form 4 at CARL (CARLSMED, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert Mittendorff II: insider trades and track record | InsiderTell